Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pfizer (Product Portfolio)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of four pharmaceutical products. The portfolio comprises of three inject able products and one inhaled solution product named as Clindamycin injection, Acetylcysteine inhalation solution, Voriconazole injection and Melphalan injection.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • New York, NY
  • United States

Pfizer (Product Portfolio) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Pfizer (Product Portfolio)‘s full profile, request access.

Request full access to PitchBook

Pfizer (Product Portfolio) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Pfizer (Product Portfolio)‘s full profile, request access.

Request full access to PitchBook